Dr. Dotan presented a case of metastatic pancreatic cancer highlighted gemcitabine for older adults, with outcomes driven by functional status, nutrition, quality of life, and ability to tolerate treatment.

Dr. Borazanci presented a case of pancreatic head cancer with biliary obstruction highlighted management challenges, including timing of drainage and the role of endoscopic, interventional radiology, or surgical approaches.

Dr. Philip presented a BRCA2-mutated pancreatic cancer case highlighted response to FOLFIRINOX, PARP inhibition, SBRT, and the emerging role of ctDNA and KRAS-targeted tools for personalized treatment.

Dr. Babiker reviewed locally advanced pancreatic cancer, highlighting tumor-treating fields plus gemcitabine, which improved survival, pain, and quality of life with consistent device use.

Experts discussed tumor-treating fields, emphasizing adherence, improved survival and pain control, endoscopic biliary management, metal stents, and emerging KRAS-targeted vaccine strategies.